Therapeutic Asset Ratings
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Zoledronate
Breast Carcinoma
Washington University School of Medicine
P4
BBB
(75)
ETOPOSIDE
Acute Myeloid Leukemia With Abnormal Bone Marrow Eosinophils Inv(16)(P13q22) Or T(16;16)(P13;Q22)
Alice Mims
P3
BBB
(75)
ETOPOSIDE
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
Alice Mims
P3
BBB
(75)
Fludarabine
Myelodysplastic/Myeloproliferative Neoplasm
Fred Hutchinson Cancer Center
P3
BBB
(75)
FLUOROURACILUM
Rectum Adenocarcinoma
Merck Sharp & Dohme LLC
P3
BBB
(75)
Glumetinib
Non-Small Cell Lung Carcinoma
Shanghai JMT-Bio Inc.
P3
BBB
(75)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Breast Carcinoma
SWOG Cancer Research Network
P3
BBB
(75)
Odronextamab
B-Cell Non-Hodgkin Lymphoma
University of Birmingham
P3
BBB
(75)
Ticagrelor
Transient Ischemic Attack
Mazandaran University of Medical Sciences
P3
BBB
(75)
ETOPOSIDE
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P2
BBB
(75)
ETOPOSIDE
Marginal Zone Lymphoma
University of Miami
P2
BBB
(75)
ETOPOSIDE
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Weill Medical College of Cornell University
P2
BBB
(75)
Metformin
Malignant Pancreatic Neoplasm
State University of New York - Downstate Medical Center
P2
BBB
(75)
Palbociclib
Her2-Receptor Negative Breast Cancer
Helwan University
P2
BBB
(75)
Romidepsin
Recurrent Mycosis Fungoides/Sezary Syndrome
Walter Hanel
P2
BBB
(75)
Anti-Thymoglobulin, Rabbit
Myelodysplastic/Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
P2/3
BBB
(75)
Cyclophosphamide
Hematologic Disorder
Baptist Health South Florida
P2/3
BBB
(75)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Migraine Disorder
Cairo University
P4
BBB
(74)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Neuralgia
Medipol University
P4
BBB
(74)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Anxiety Disorder
Theresa Jacob, PhD, MPH
P4
BBB
(74)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Chronic Pain Syndrome
Stanford University
P4
BBB
(74)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Depressive Disorder
VA Office of Research and Development
P4
BBB
(74)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Neuralgia
Margaux M. Salas, PhD
P4
BBB
(74)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Post-Operative Pain, Non-Human Animal
Tanta University
P4
BBB
(74)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Post-Traumatic Stress Disorder
Queen's University
P4
BBB
(74)
Showing 451 to 475 of 61,847 assets
Previous
Page 19 of 2474
Next